Optimal targeting of PI3K-AKT and mTOR in advanced oestrogen receptor-positive breast cancer
Year: 2024
Type: article
Source: The Lancet Oncology
Institutions: Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Breast Cancer Now, Royal Marsden Hospital, Inserm, Université Paris-Saclay, Institut Gustave Roussy, Memorial Sloan Kettering Cancer Center, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4393176990
